Abstract Number: 1094 • 2014 ACR/ARHP Annual Meeting
Work Productivity and Healthcare Utilization in Patients with Fibromyalgia and Comorbid Depression Taking Antidepressant Medication
Background/Purpose Patients with fibromyalgia (FM) experience pain, sleep disruption, fatigue, and other symptoms that limit activity, impacting work productivity and increasing healthcare utilization. Here, we…Abstract Number: 2056 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Symptoms Beyond the Pain and Its Impact on the Patient
Background/Purpose: Fibromyalgia (FM) has been promoted as the commonest cause of chronic, widespread non-articular musculoskeletal pain, stiffness and fatigue. Although pain is the central feature…Abstract Number: 894 • 2014 ACR/ARHP Annual Meeting
Small Fiber Neuropathy in Women with Fibromyalgia. a Clinical-Pathological Correlation Using Confocal Corneal Biomicroscopy
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome (Semin Arthritis Rheum 2000;29:197). This view has been recently reinforced…Abstract Number: 2055 • 2014 ACR/ARHP Annual Meeting
Are There Immunological Abnormalities in Fibromyalgia Patients: Flow Cytometry Analysis
Background/Purpose: Fibromyalgia is not thought to have an immunological pathogenesis: However, few studies have been done to evaluate immunological abnormalities. We analyzed lymphocyte subsets in…Abstract Number: 401 • 2014 ACR/ARHP Annual Meeting
Association of Anti-Thyroid Autoantibodies with Fibromyalgia in Rheumatoid Arthritis
Background/Purpose Autoimmune thyroiditis has been linked independently with fibromyalgia and chronic widespread pain. We studied how the presence of autoimmune thyroiditis affects the clinical presentation…Abstract Number: 1879 • 2014 ACR/ARHP Annual Meeting
The Efficacy of Pregabalin for Treating Fibromyalgia Patients with Moderate or Severe Baseline Widespread Pain
Background/Purpose: Pregabalin has demonstrated efficacy for the treatment of fibromyalgia (FM), but insufficient evidence exists on how the efficacy of pregabalin may differ by baseline…Abstract Number: 252 • 2014 ACR/ARHP Annual Meeting
Preliminary Validation of the Michigan Body Map
Background/Purpose One of the hallmark features of fibromyalgia and other centralized pain states is widespread body pain. We developed the Michigan Body Map (MBM) to…Abstract Number: 1869 • 2014 ACR/ARHP Annual Meeting
Child Pain, Function, and Psychological Outcomes in an Intensive Interdisciplinary Pediatric Pain Rehabilitation Program
Background/Purpose: We examined the functional, psychological, and pain-related outcomes among children with chronic pain completing an intensive interdisciplinary pediatric pain rehabilitation program. We hypothesized that…Abstract Number: 2849 • 2013 ACR/ARHP Annual Meeting
Medication Adherence and Healthcare Costs Among Patients With Fibromyalgia: Combination Medication Versus Duloxetine, Pregabalin, and Milnacipran Initiators
Background/Purpose: The combined use of prescription drugs (Rx) with complementary mechanisms of action has been described for treating fibromyalgia (FM). We examined medication adherence and…Abstract Number: 2850 • 2013 ACR/ARHP Annual Meeting
Once Daily Controlled-Release Pregabalin In Fibromyalgia Patients: A Phase 3 Double-Blind, Randomized Withdrawal, Placebo-Controlled Study
Background/Purpose: Pregabalin (PGB) is currently approved for the treatment of fibromyalgia (FM) for twice daily dosing over a range of 300-450 mg/day. A pregabalin controlled-release…Abstract Number: 2852 • 2013 ACR/ARHP Annual Meeting
Real-Life Assessment Of The Validity Of Patient Global Impression Of Change In Fibromyalgia
Background/Purpose: Assessing fibromyalgia (FM) is challenging due to the lack of hard outcomes and the need to rely on patient-reported symptoms. Completion of questionnaires by…Abstract Number: 2092 • 2013 ACR/ARHP Annual Meeting
Strengthening Exercises Using A Swiss Ball Improve Symptoms and Muscle Performance Of Patients With Fibromyalgia: A Randomized Controlled Study
Background/Purpose: Fibromyalgia (FM) is a disorder characterized by chronic widespread pain, fatigue and reduced muscle strength. Exercise is fundamental to the treatment of FM and…Abstract Number: 1948 • 2013 ACR/ARHP Annual Meeting
Power Doppler Ultrasound 7-Joint Score Vs. Simplified Disease Activity Index In Rheumatoid Arthritis Associated With Fibromyalgia
Background/Purpose: Fibromyalgia (FM) falsely increases rheumatoid arthritis (RA) disease activity clinical composite scores, such as the simplified disease activity index (SDAI), recently incorporated into ACR/EULAR…Abstract Number: 140 • 2013 ACR/ARHP Annual Meeting
Fibromyalgia and Pregnancy: Challenges Of The Savella® (Milnacipran) Pregnancy Registry
Background/Purpose: During pregnancy, women with fibromyalgia (FM) often experience worsening of symptoms, which include widespread pain, fatigue, sleep disturbances, cognitive difficulties, and reduced daily functioning.…Abstract Number: 1101 • 2013 ACR/ARHP Annual Meeting
Neuromuscular Taping On Patients With Fibromyalgia May Be a Useful Tool To Relief Muscular Pain
Background/Purpose: Fibromyalgia (FMS) is an illness characterized by an anomalous perception of the painful stimuli that are supposed to be attributable to a combination of…
- « Previous Page
- 1
- …
- 17
- 18
- 19
- 20
- 21
- …
- 23
- Next Page »